Medpace Holdings Property, Plant, and Equipment 2014-2024 | MEDP

Medpace Holdings property, plant, and equipment from 2014 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Medpace Holdings property, plant, and equipment for the quarter ending September 30, 2024 was $0.124B, a 8.1% increase year-over-year.
  • Medpace Holdings property, plant, and equipment for 2023 was $0.121B, a 9.78% increase from 2022.
  • Medpace Holdings property, plant, and equipment for 2022 was $0.11B, a 17.92% increase from 2021.
  • Medpace Holdings property, plant, and equipment for 2021 was $0.093B, a 9.57% increase from 2020.
Medpace Holdings Annual Property, Plant, and Equipment
(Millions of US $)
2023 $121
2022 $110
2021 $93
2020 $85
2019 $47
2018 $52
2017 $49
2016 $44
2015 $38
2014 $38
2013 $
Medpace Holdings Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-09-30 $124
2024-06-30 $122
2024-03-31 $119
2023-12-31 $121
2023-09-30 $115
2023-06-30 $115
2023-03-31 $114
2022-12-31 $110
2022-09-30 $105
2022-06-30 $104
2022-03-31 $99
2021-12-31 $93
2021-09-30 $88
2021-06-30 $86
2021-03-31 $85
2020-12-31 $85
2020-09-30 $71
2020-06-30 $66
2020-03-31 $50
2019-12-31 $47
2019-09-30 $44
2019-06-30 $40
2019-03-31 $38
2018-12-31 $52
2018-09-30 $52
2018-06-30 $52
2018-03-31 $51
2017-12-31 $49
2017-09-30 $46
2017-06-30 $45
2017-03-31 $45
2016-12-31 $44
2016-09-30 $41
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2014-12-31 $43
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $10.906B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $88.397B 10.97
Cencora (COR) United States $45.651B 17.16
Natera (NTRA) United States $23.104B 0.00
DiDi Global (DIDIY) China $21.969B 0.00
ICON (ICLR) Ireland $18.002B 16.03
Avantor (AVTR) United States $14.742B 22.10
Viatris (VTRS) United States $13.929B 4.29
Revvity (RVTY) United States $13.859B 24.08
BioMerieux (BMXMF) France $12.558B 0.00
CochLear (CHEOY) Australia $12.074B 0.00
Solventum (SOLV) United States $11.587B 0.00
Doximity (DOCS) United States $9.727B 57.25
EUROFINS SCIENT (ERFSF) Luxembourg $9.707B 0.00
Charles River Laboratories (CRL) United States $9.517B 18.39
HealthEquity (HQY) United States $8.694B 43.62
Sonic Healthcare (SKHHY) Australia $8.191B 0.00
Bausch + Lomb (BLCO) Canada $6.259B 29.11
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Organon (OGN) United States $4.082B 4.12
Sotera Health (SHC) United States $3.713B 19.86
BrightSpring Health Services (BTSG) United States $2.990B 63.59
Surgery Partners (SGRY) United States $2.625B 29.93
Concentras Parent (CON) United States $2.513B 0.00
GeneDx Holdings (WGS) United States $2.455B 0.00
Alignment Healthcare (ALHC) United States $2.277B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.006B 10.44
PACS (PACS) United States $1.955B 0.00
GoodRx Holdings (GDRX) United States $1.734B 45.50
Teladoc Health (TDOC) United States $1.699B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Progyny (PGNY) United States $1.597B 32.34
Establishment Labs Holdings (ESTA) $1.282B 0.00
CareDx (CDNA) United States $1.267B 0.00
Embecta (EMBC) United States $1.132B 7.92
Pediatrix Medical (MD) United States $1.068B 10.45
AMN Healthcare Services Inc (AMN) United States $1.023B 6.93
Agilon Health (AGL) United States $1.001B 0.00
QDM (QDMI) Hong Kong, SAR China $0.563B 14.73
SBC Medicals (SBC) United States $0.526B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
InnovAge Holding (INNV) United States $0.490B 0.00
DocGo (DCGO) United States $0.416B 15.69
Sonida Senior Living (SNDA) United States $0.409B 0.00
Enhabit (EHAB) United States $0.382B 33.04
COMPASS Pathways (CMPS) United Kingdom $0.242B 0.00
Sera Prognostics (SERA) United States $0.234B 0.00
MultiPlan (MPLN) United States $0.206B 0.00
LifeMD (LFMD) United States $0.205B 0.00
Performant Healthcare (PHLT) United States $0.197B 0.00
Beauty Health (SKIN) United States $0.192B 0.00
Biodesix (BDSX) United States $0.185B 0.00
Nutex Health (NUTX) United States $0.168B 0.00
So-Young (SY) China $0.104B 17.70
ModivCare (MODV) United States $0.094B 5.09
Ascend Wellness Holdings (AAWH) United States $0.092B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.026B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00